Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines - PubMed (original) (raw)
. 2011 Mar 1;81(5):586-93.
doi: 10.1016/j.bcp.2010.12.009. Epub 2010 Dec 17.
Affiliations
- PMID: 21168391
- DOI: 10.1016/j.bcp.2010.12.009
Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines
L Bastin-Coyette et al. Biochem Pharmacol. 2011.
Abstract
Nucleoside analogs (NAs) represent an important class of anticancer agents that induce cell death after conversion to triphosphate derivatives. One of their most important mechanisms of action is the activation of p53, leading to apoptosis through the intrinsic pathway. Classically, the activation of p53 also induces p21 accumulation, which leads to cell cycle arrest at the G1/S transition. In previous work, we observed that 2-chloro-2'-deoxyadenosine (CdA), a NA with high activity in lymphoid disorders, including chronic lymphocytic leukemia (CLL), promotes the G1/S transition in the CLL cell line EHEB at cytotoxic concentrations. This finding led us to investigate the p21 response to NAs in these cells. We show here that CdA, but also fludarabine, gemcitabine, and cytarabine, strongly reduced the p21 protein level in EHEB cells as well as in JVM-2 cells, another CLL cell line. This p21 depletion occurred despite induction of p53 and increase of p21 mRNA and was prevented by proteasome inhibitors. Increase of proteasomal degradation caused by NAs appeared to be ubiquitin-independent. Also, NAs induced in these cells an increase of cyclin-dependent kinase (Cdk2) activity and a monoubiquitination of cell proliferating nuclear antigen (PCNA), two processes that are negatively regulated by p21. These changes were not observed with other p53 activators, like etoposide and nutlin-3a that increased the p21 protein level. In conclusion, our study reveals that NAs can induce an alternative pattern of cellular response in some cell models.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
- Effects of 2-chloro-2'-deoxyadenosine on the cell cycle in the human leukemia EHEB cell line.
Cardoen S, Van den Neste E, Smal C, Rosier JF, Ferrant A, Van den Berghe G, Bontemps F. Cardoen S, et al. Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1425-9. doi: 10.1081/NCN-200027653. Nucleosides Nucleotides Nucleic Acids. 2004. PMID: 15571271 - Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
Van den Neste E, Cardoen S, Offner F, Bontemps F. Van den Neste E, et al. Int J Oncol. 2005 Oct;27(4):1113-24. Int J Oncol. 2005. PMID: 16142330 Review. - Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues.
Pettitt AR, Sherrington PD, Cawley JC. Pettitt AR, et al. Cancer Res. 2000 Aug 1;60(15):4187-93. Cancer Res. 2000. PMID: 10945628 - Mechanism of action of purine analogues in chronic lymphocytic leukaemia.
Pettitt AR. Pettitt AR. Br J Haematol. 2003 Jun;121(5):692-702. doi: 10.1046/j.1365-2141.2003.04336.x. Br J Haematol. 2003. PMID: 12780783 Review. No abstract available.
Cited by
- Beneficial Effect of Olive Oil and Its Derivates: Focus on Hematological Neoplasm.
Campo C, Gangemi S, Pioggia G, Allegra A. Campo C, et al. Life (Basel). 2024 Apr 30;14(5):583. doi: 10.3390/life14050583. Life (Basel). 2024. PMID: 38792604 Free PMC article. Review. - The Effect of Dietary Intervention With High-Oleocanthal and Oleacein Olive Oil in Patients With Early-Stage Chronic Lymphocytic Leukemia: A Pilot Randomized Trial.
Rojas Gil AP, Kodonis I, Ioannidis A, Nomikos T, Dimopoulos I, Kosmidis G, Katsa ME, Melliou E, Magiatis P. Rojas Gil AP, et al. Front Oncol. 2022 Jan 21;11:810249. doi: 10.3389/fonc.2021.810249. eCollection 2021. Front Oncol. 2022. PMID: 35127522 Free PMC article. - The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1.
Knecht KM, Buzovetsky O, Schneider C, Thomas D, Srikanth V, Kaderali L, Tofoleanu F, Reiss K, Ferreirós N, Geisslinger G, Batista VS, Ji X, Cinatl J Jr, Keppler OT, Xiong Y. Knecht KM, et al. Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10022-E10031. doi: 10.1073/pnas.1805593115. Epub 2018 Oct 10. Proc Natl Acad Sci U S A. 2018. PMID: 30305425 Free PMC article. - Chk1 inhibition significantly potentiates activity of nucleoside analogs in TP53-mutated B-lymphoid cells.
Zemanova J, Hylse O, Collakova J, Vesely P, Oltova A, Borsky M, Zaprazna K, Kasparkova M, Janovska P, Verner J, Kohoutek J, Dzimkova M, Bryja V, Jaskova Z, Brychtova Y, Paruch K, Trbusek M. Zemanova J, et al. Oncotarget. 2016 Sep 20;7(38):62091-62106. doi: 10.18632/oncotarget.11388. Oncotarget. 2016. PMID: 27556692 Free PMC article. - p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
Davies C, Hogarth LA, Mackenzie KL, Hall AG, Lock RB. Davies C, et al. Cell Cycle. 2015;14(22):3602-12. doi: 10.1080/15384101.2015.1100774. Cell Cycle. 2015. PMID: 26506264 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous